Merck Millipore is now Merck

Emerging Biotech Grant Program

Are you ready to unlock your molecule's potential?

Apply to our 2016 European Emerging Biotech Grant Program Today!

It is our goal to help advance lifesaving drugs to market. We understand the challenges emerging biotech companies face in the quest to push the next generation of drugs to market and we want to help you succeed!

That's why we're inviting you to apply to our 2016 European Emerging Biotech Grant Program. There are a total of 4 awards: First Prize is €100k, Second prize is €50k, Third and Fourth prizes are €25k each in products and services, including:

  • Buffers, Filters, and Resins
  • Lab-scale Hardware
  • Upstream Services
  • Consultation Services

To enter, please submit a completed application and tell us about your molecule before 1st October, 2016. Good luck!

Submit Application

[Not ready to apply? Simply submit the application, with only contact information and we'll make sure you learn more about the program.]

Each molecule holds the promise of becoming a lifesaving drug. Learn how we can help you realize the potential of your molecule.


Official Rules

iPad® Tablet Giveaway!

Submit your application before 1st July 2016 to be entered into a separate giveaway for an iPad® tablet.

More Info

Application submissions will be judged by a qualified Merck KGaA, Darmstadt, Germany panel of judges, based on the following objective criteria of equal weight: (i) the scientific and societal merit of the therapy being developed, and (ii) process challenges and expertise gaps associated with the development of the therapy. See official program rules for full details. Note. The closing date for submission of Grant applications is midnight on 30th September 2016. Each Application received by midnight on 30th June 2016 will also have the chance to win an iPad tablet. Please refer to the official rules for the Grant and to win an iPad® tablet. Winner selected, informed and announced on or around 15th November 2016.
2017 Life Science Executive Summit - Executive Invitation

12 January 2017, Menlo Park, California: Concept to Clinic: Bringing your molecule to market - A unique opportunity to network with your peers and the senior executives of Merck.

Register >

2016 EU Grant Program

Tell us about your molecule and apply to receive up to €100k in products and services. Winners announced soon.

More >

WEBINAR: RNA Based Therapeutics and Vaccines: Bioprocessing Technology Trends

Review the current dynamics in the RNA therapeutics/vaccines market with a focus on process development and manufacturing strategies.

Watch this Webinar >

Webinars On-Demand >

The Changing Biopharma Risk Equation

A report from the The Economist Intelligence Unit sponsored by Merck.
This paper, which incorporates the results of a survey of 254 pharmaceutical executives from around the world and a range of interviews with industry experts, explores in detail global pharmaceutical companies' growth strategies and their plans for managing the associated risks.

Read the study >

The Online Edge

How a digital presence can accelerate your startup’s growth.
You and a handful of associates have launched a small biotech startup that has pinned its growth on the development of a single promising molecule. But as markets shift to a more mature model, new differentiators have come into play that in turn can determine both short- and long-term success for biotech startups. As authors Tsai and Erickson point out, having a sound business strategy from the start is key. Download this white paper to learn more on how creating an online presence for your startup makes perfect marketing sense.

Read the study >

Contact Us

Research. Development. Production.

We are a leading supplier to the global Life Science industry: solutions and services for research, development and production of biotechnology and pharmaceutical drug therapies.

Copyright © 2016 Merck KGaA. All rights reserved.
Merck Millipore is a part of Merck.